Success Stories: EB-1B Petition Approved for Scientist in Kentucky in the Field of Plant Science
Client’s Testimonial:
I appreciate your help right when I needed it most. Thanks!
We Received EB-1B Approval for a Scientist in the Field of Plant Science on March 26, 2015 (Approval Notice)
Position at the Time of Case Filing: Scientist
Petitioner: A Public University
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Kentucky
Approval Notice Date: March 26th, 2015
Processing Time: 22 Days (7 Days After Requesting Premium Processing)
At North America Immigration Law Group, we recently received an EB-1B approval for a plant scientist from India. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB-1B petition. His specialized research has focused on metabolically engineering plants to produce secondary metabolites of medicinal and economic value. His research work had resulted in 15 peer-reviewed scientific articles, 5 NIH GENBANK submissions, and numerous presentations at national and international conferences. He had also reviewed 5 manuscripts for prominent internationally-circulated journals at the time we filed the case. Furthermore, the beneficiary had a total of 257 citations to his work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. The petitioner in this case was a private company. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “[Client’s] work is a breakthrough in obtaining compounds of significant medicinal value from a limited number of plants ... Such plants…are rich sources of 140+ medically significant alkaloids …The growing demand for alkaloids in the pharmaceutical industry has made these compounds extremely expensive due to the difficulty of obtaining sufficient quantities…[Client] was one of the first researchers to provide insight into the transcription factors and genes regulating the TIA pathway, providing viable solutions for engineering methods of obtaining lifesaving drugs.” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. With the proof and documentation that we provided, his case was approved in twenty-two days.